Cutler Group LP Compass Pathways PLC Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	BUY	$10.73 - $20.07 $1,073 - $2,007	100 New	100 $1,000
Q1 2022 Apr 14, 2022	SELL	$11.13 - $23.04 $119,091 - $246,528	-10,700 Reduced 41.0%	15,400 $263,000
Q4 2021 Jan 18, 2022	SELL	$21.81 - $48.96 $314,064 - $705,024	-14,400 Reduced 35.56%	26,100 $206,000
Q3 2021 Oct 26, 2021	BUY	$29.03 - $38.62 $978,311 - $1.3 Million	33,700 Added 495.59%	40,500 $242,000
Q2 2021 Jul 19, 2021	SELL	$32.29 - $39.68 $6,458 - $7,936	-200 Reduced 2.86%	6,800 $24,000
Q1 2021 Apr 26, 2021	SELL	$34.75 - $57.5 $83,400 - $138,000	-2,400 Reduced 25.53%	7,000 $25,000
Q4 2020 Jan 21, 2021	BUY	$32.0 - $59.2 $300,800 - $556,480	9,400 New	9,400 $19,000

144

29.3M

156K

563K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.